Ron Steckel

Ron’s extensive experience with start-ups encompasses a broad range of corporate strategies, novel and disruptive technologies, diverse management teams and changes in the clinical, regulatory and reimbursement landscape. Ron has held multiple operating leadership roles, including: President & CEO of Pulmonx, Chief Operating Officer of FoxHollow, and Vice-President of Operations for Iridex. His experience comprises over 35 years of domestic and international positions in the medical device, diagnostics and pharmaceutical industries including major corporations and private companies.